Compare Bills

Primary Sponsor

Last Action

Ref To Com On Rules and Operations of the Senate2025-03-26

Vote Breakdown

Plain Language Summary

This bill updates North Carolina's Controlled Substances Act by adding dozens of newly synthesized drugs to the state's Schedule I and Schedule II controlled substance lists. These additions include synthetic opioids (such as U-47700 variants and nitazene derivatives), fentanyl derivatives, synthetic cannabinoids, and other designer drugs, while also making minor corrections to existing drug names in the statute.

Arguments in Favor

• •Supporters argue this bill helps law enforcement combat the emergence of dangerous designer drugs that are chemically modified to evade existing drug laws.
• •By listing these new synthetic substances—particularly dangerous opioids and fentanyl analogs linked to overdose deaths—the state can prosecute their manufacture and distribution.
• •Proponents contend the bill closes legal loopholes that allow drug manufacturers to create slightly altered versions of banned substances and sell them while remaining technically legal.

Arguments Against

• •Opponents may question whether listing individual drug variants is the most effective approach, since chemists can continually create new modifications faster than legislatures can ban them.
• •Some argue the bill's broad language defining structural classes of drugs could inadvertently affect legitimate research, pharmaceutical manufacturing, or industrial uses unless exemptions are carefully applied.
• •Critics might also contend that aggressive scheduling alone doesn't address underlying addiction and overdose issues without accompanying treatment and prevention resources.